Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Subcloning and antiviral phenotype segregation in pancreatic cancer cell line subpopulations.

PAOLINELLI, Francesca
COIN, Silvia
Brutti, Nadia
INNAMORATI, Giulio
MONSURRO', Vladia
Marzioni D
Farronato M
Lorenzi T
Castellucci M

Publication date

January 2010

Abstract

Subcloning in pancreatic cancer cell lines of the antiviral phenotype segregation

Extracted data

Related items

Identification of a Novel Subpopulation of Tumor- Initiating Cells from Gemcitabine-Resistant Pancreatic Ductal Adenocarcinoma

Kazuya Shimizu
Sachie Chiba
Yuichi Hori

January 2013

Pancreatic ductal adenocarcinoma is highly resistant to systemic chemotherapy. Although there are ma...

Clinical Impact of Molecular Subtyping of Pancreatic Cancer

Zhou Xu
Zhou Xu
Kai Hu
Kai Hu
Peter Bailey
Peter Bailey
Peter Bailey
Christoph Springfeld
Susanne Roth
Roma Kurilov
Benedikt Brors
Benedikt Brors
Thomas Gress
Malte Buchholz
Jingyu An
Jingyu An
Kongyuan Wei
Kongyuan Wei
Teresa Peccerella
Teresa Peccerella
Markus W. Büchler
Thilo Hackert
John P. Neoptolemos
John P. Neoptolemos

November 2021

Pancreatic ductal adenocarcinoma is a highly lethal malignancy, which has now become the seventh mos...

Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.

Niess, H.
Camaj, P.
Renner, A.
Ischenko, I.
Zhao, Y.
Krebs, S.
Mysliwietz, J.
Jäckel, C.
Nelson, P.J.
Blum, H.
Jauch, K.W.
Ellwart, J.W.
Bruns, C.J.

January 2015

Cancer stem cells (CSCs) have been proposed to underlie the initiation and maintenance of tumor grow...

Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene therapy

V. Monsurro'
R. Wang
G. Di Pasquale
A. Worschech
J. A. Chiorini
H. Alter
F. M. Marincola
BEGHELLI, Stefania
BARBI, Stefano
COIN, Silvia
BERSANI, Samantha
CASTELLUCCI, Monica
SORIO, Claudio
ELEUTERI, Stefano
PEDERZOLI, Paolo
SCARPA, Aldo

January 2009

In the present work we classified using genetic signature two subgroups of human pancreatic tumors, ...

Establishment and Characterization of 4 New Human Pancreatic Cancer Cell Lines: Evidences of Different Tumor Phenotypes

CHIFENTI B
MORELLI M
ZAVAGLIA M
COVIELLO DA
GUERNERI S
MASETTI M
LOCCI MT
BERTACCA G
CAPODANNO A
COLLECCHI P
CAMPANI D
MOSCA F
BEVILACQUA G
CAVAZZANA AO
SANTUCCI, ANNALISA
PAFFETTI, ALESSANDRO

January 2009

OBJECTIVES: Pancreatic cancer still remains a challenge for its biological complexity and lack of ef...

Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells

Jaiswal, Kshama R.
Xin, Hong-Wu
Anderson, Andrew
Wiegand, Gordon
Kim, Bo
Miller, Tyler
Hari, Danielle
Ray, Satyajit
Koizumi, Tomotake
Rudloff, Udo
Thorgeirsson, Snorri S.
Avital, Itzhak

November 2012

AbstractNo systemic therapy is effective against pancreatic cancer (PC). Pancreatic cancer stem cell...

Molecular subtypes of pancreatic cancer

Collisson, Eric A.
Bailey, Peter
Chang, David K.
Biankin, Andrew V.

April 2019

Cancers that appear morphologically similar often have dramatically different clinical features, res...

Subtypes of Pancreatic Cancer

Andrews University

October 2016

Published on Oct 24, 2016 Subtypes of Pancreatic Cancer Presented by Brian B. Haabhttps://digita...

The heterogeneity of CAFs and immune cell populations in the tumor microenvironment of pancreatic adenocarcinoma

Diab, Maria
El-Rayes, Bassel F.

September 2022

Over the past decade, researchers have identified and characterized the diverse cell populations wit...

Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients.

Kazuya Shimizu
Sachie Chiba
Yuichi Hori

Pancreatic ductal adenocarcinoma is highly resistant to systemic chemotherapy. Although there are ma...

Image_1_PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.jpeg

Biao Zhang (148194)
Bingqian Huang (10268798)
Xiaonan Zhang (538829)
Shuang Li (146392)
Jingyi Zhu (1282827)
Xu Chen (432759)
Huiyi Song (9537088)
Dong Shang (4990103)

July 2023

BackgroundPANoptosis is an inflammatory type of programmed cell death regulated by PANopotosome. Mou...

Image_3_PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.jpeg

Biao Zhang (148194)
Bingqian Huang (10268798)
Xiaonan Zhang (538829)
Shuang Li (146392)
Jingyi Zhu (1282827)
Xu Chen (432759)
Huiyi Song (9537088)
Dong Shang (4990103)

July 2023

BackgroundPANoptosis is an inflammatory type of programmed cell death regulated by PANopotosome. Mou...

Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy

Chiorini Jay A
Worschech Andrea
Sorio Claudio
Eleuteri Stefano
Castellucci Monica
Bersani Samantha
Di Pasquale Giovanni
Coin Silvia
Barbi Stefano
Wang Richard
Beghelli Stefania
Monsurrò Vladia
Pederzoli Paolo
Alter Harvey
Marincola Francesco M
Scarpa Aldo

January 2010

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer mortal...

Image_2_PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.jpeg

Biao Zhang (148194)
Bingqian Huang (10268798)
Xiaonan Zhang (538829)
Shuang Li (146392)
Jingyi Zhu (1282827)
Xu Chen (432759)
Huiyi Song (9537088)
Dong Shang (4990103)

July 2023

BackgroundPANoptosis is an inflammatory type of programmed cell death regulated by PANopotosome. Mou...

Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors

Sahil Seth
Chieh-Yuan Li
I-Lin Ho
Denise Corti
Sara Loponte
Luigi Sapio
Edoardo Del Poggetto
Er-Yen Yen
Frederick Scott Robinson
Michael Peoples
Tatiana Karpinets
Angela Kay Deem
Tapsi Kumar
Xingzhi Song
Shan Jiang
Ya’an Kang
Jason Fleming
Michael Kim
Jianhua Zhang
Anirban Maitra
Timothy Paul Heffernan
Virginia Giuliani
Giannicola Genovese
Andrew Futreal
Giulio Francesco Draetta
Alessandro Carugo
Andrea Viale

February 2019

Summary: Adaptive drug-resistance mechanisms allow human tumors to evade treatment through selection...

Identification of a Novel Subpopulation of Tumor- Initiating Cells from Gemcitabine-Resistant Pancreatic Ductal Adenocarcinoma

Kazuya Shimizu
Sachie Chiba
Yuichi Hori

January 2013

Pancreatic ductal adenocarcinoma is highly resistant to systemic chemotherapy. Although there are ma...

Clinical Impact of Molecular Subtyping of Pancreatic Cancer

Zhou Xu
Zhou Xu
Kai Hu
Kai Hu
Peter Bailey
Peter Bailey
Peter Bailey
Christoph Springfeld
Susanne Roth
Roma Kurilov
Benedikt Brors
Benedikt Brors
Thomas Gress
Malte Buchholz
Jingyu An
Jingyu An
Kongyuan Wei
Kongyuan Wei
Teresa Peccerella
Teresa Peccerella
Markus W. Büchler
Thilo Hackert
John P. Neoptolemos
John P. Neoptolemos

November 2021

Pancreatic ductal adenocarcinoma is a highly lethal malignancy, which has now become the seventh mos...

Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.

Niess, H.
Camaj, P.
Renner, A.
Ischenko, I.
Zhao, Y.
Krebs, S.
Mysliwietz, J.
Jäckel, C.
Nelson, P.J.
Blum, H.
Jauch, K.W.
Ellwart, J.W.
Bruns, C.J.

January 2015

Cancer stem cells (CSCs) have been proposed to underlie the initiation and maintenance of tumor grow...

Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene therapy

V. Monsurro'
R. Wang
G. Di Pasquale
A. Worschech
J. A. Chiorini
H. Alter
F. M. Marincola
BEGHELLI, Stefania
BARBI, Stefano
COIN, Silvia
BERSANI, Samantha
CASTELLUCCI, Monica
SORIO, Claudio
ELEUTERI, Stefano
PEDERZOLI, Paolo
SCARPA, Aldo

January 2009

In the present work we classified using genetic signature two subgroups of human pancreatic tumors, ...

Establishment and Characterization of 4 New Human Pancreatic Cancer Cell Lines: Evidences of Different Tumor Phenotypes

CHIFENTI B
MORELLI M
ZAVAGLIA M
COVIELLO DA
GUERNERI S
MASETTI M
LOCCI MT
BERTACCA G
CAPODANNO A
COLLECCHI P
CAMPANI D
MOSCA F
BEVILACQUA G
CAVAZZANA AO
SANTUCCI, ANNALISA
PAFFETTI, ALESSANDRO

January 2009

OBJECTIVES: Pancreatic cancer still remains a challenge for its biological complexity and lack of ef...

Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells

Jaiswal, Kshama R.
Xin, Hong-Wu
Anderson, Andrew
Wiegand, Gordon
Kim, Bo
Miller, Tyler
Hari, Danielle
Ray, Satyajit
Koizumi, Tomotake
Rudloff, Udo
Thorgeirsson, Snorri S.
Avital, Itzhak

November 2012

AbstractNo systemic therapy is effective against pancreatic cancer (PC). Pancreatic cancer stem cell...

Molecular subtypes of pancreatic cancer

Collisson, Eric A.
Bailey, Peter
Chang, David K.
Biankin, Andrew V.

April 2019

Cancers that appear morphologically similar often have dramatically different clinical features, res...

Subtypes of Pancreatic Cancer

Andrews University

October 2016

Published on Oct 24, 2016 Subtypes of Pancreatic Cancer Presented by Brian B. Haabhttps://digita...

The heterogeneity of CAFs and immune cell populations in the tumor microenvironment of pancreatic adenocarcinoma

Diab, Maria
El-Rayes, Bassel F.

September 2022

Over the past decade, researchers have identified and characterized the diverse cell populations wit...

Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients.

Kazuya Shimizu
Sachie Chiba
Yuichi Hori

Pancreatic ductal adenocarcinoma is highly resistant to systemic chemotherapy. Although there are ma...

Image_1_PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.jpeg

Biao Zhang (148194)
Bingqian Huang (10268798)
Xiaonan Zhang (538829)
Shuang Li (146392)
Jingyi Zhu (1282827)
Xu Chen (432759)
Huiyi Song (9537088)
Dong Shang (4990103)

July 2023

BackgroundPANoptosis is an inflammatory type of programmed cell death regulated by PANopotosome. Mou...

Image_3_PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.jpeg

Biao Zhang (148194)
Bingqian Huang (10268798)
Xiaonan Zhang (538829)
Shuang Li (146392)
Jingyi Zhu (1282827)
Xu Chen (432759)
Huiyi Song (9537088)
Dong Shang (4990103)

July 2023

BackgroundPANoptosis is an inflammatory type of programmed cell death regulated by PANopotosome. Mou...

Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy

Chiorini Jay A
Worschech Andrea
Sorio Claudio
Eleuteri Stefano
Castellucci Monica
Bersani Samantha
Di Pasquale Giovanni
Coin Silvia
Barbi Stefano
Wang Richard
Beghelli Stefania
Monsurrò Vladia
Pederzoli Paolo
Alter Harvey
Marincola Francesco M
Scarpa Aldo

January 2010

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer mortal...

Image_2_PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.jpeg

Biao Zhang (148194)
Bingqian Huang (10268798)
Xiaonan Zhang (538829)
Shuang Li (146392)
Jingyi Zhu (1282827)
Xu Chen (432759)
Huiyi Song (9537088)
Dong Shang (4990103)

July 2023

BackgroundPANoptosis is an inflammatory type of programmed cell death regulated by PANopotosome. Mou...

Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors

Sahil Seth
Chieh-Yuan Li
I-Lin Ho
Denise Corti
Sara Loponte
Luigi Sapio
Edoardo Del Poggetto
Er-Yen Yen
Frederick Scott Robinson
Michael Peoples
Tatiana Karpinets
Angela Kay Deem
Tapsi Kumar
Xingzhi Song
Shan Jiang
Ya’an Kang
Jason Fleming
Michael Kim
Jianhua Zhang
Anirban Maitra
Timothy Paul Heffernan
Virginia Giuliani
Giannicola Genovese
Andrew Futreal
Giulio Francesco Draetta
Alessandro Carugo
Andrea Viale

February 2019

Summary: Adaptive drug-resistance mechanisms allow human tumors to evade treatment through selection...

Identification of a Novel Subpopulation of Tumor- Initiating Cells from Gemcitabine-Resistant Pancreatic Ductal Adenocarcinoma

Kazuya Shimizu
Sachie Chiba
Yuichi Hori

January 2013

Pancreatic ductal adenocarcinoma is highly resistant to systemic chemotherapy. Although there are ma...

Clinical Impact of Molecular Subtyping of Pancreatic Cancer

Zhou Xu
Zhou Xu
Kai Hu
Kai Hu
Peter Bailey
Peter Bailey
Peter Bailey
Christoph Springfeld
Susanne Roth
Roma Kurilov
Benedikt Brors
Benedikt Brors
Thomas Gress
Malte Buchholz
Jingyu An
Jingyu An
Kongyuan Wei
Kongyuan Wei
Teresa Peccerella
Teresa Peccerella
Markus W. Büchler
Thilo Hackert
John P. Neoptolemos
John P. Neoptolemos

November 2021

Pancreatic ductal adenocarcinoma is a highly lethal malignancy, which has now become the seventh mos...

Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.

Niess, H.
Camaj, P.
Renner, A.
Ischenko, I.
Zhao, Y.
Krebs, S.
Mysliwietz, J.
Jäckel, C.
Nelson, P.J.
Blum, H.
Jauch, K.W.
Ellwart, J.W.
Bruns, C.J.

January 2015

Cancer stem cells (CSCs) have been proposed to underlie the initiation and maintenance of tumor grow...